461 related articles for article (PubMed ID: 16273254)
61. [Results of a combination of platinum-vindesin-ametycin-bleomycin (CEMB) in the treatment of stage IV non-small-cell lung cancers].
Souquet PJ; Fournel P; Jorda M; Laennec E; Piperno D; Trillet V; Rebattu P; Bernard JP
Bull Cancer; 1993 Jan; 80(1):80-2. PubMed ID: 7515730
[TBL] [Abstract][Full Text] [Related]
62. Outcome of metastatic non-small cell lung carcinoma patients receiving docetaxelcisplatin combination chemotherapy: single institution experience.
Kocak M; Mayadagli A; Ozkan A; Parlak C; Demir O; Marti A; Dogan Eren M; Kaya S; Gumus M
J BUON; 2007; 12(4):471-6. PubMed ID: 18067204
[TBL] [Abstract][Full Text] [Related]
63. Second-line chemotherapy in small cell lung cancer in a modified administration of topotecan combined with paclitaxel: a phase II study.
Stathopoulos GP; Christodoulou Ch; Stathopoulos J; Skarlos D; Rigatos SK; Giannakakis T; Armenaki O; Antoniou D; Athanasiadis A; Giamboudakis P; Dimitroulis J; Georgatou N; Katis K
Cancer Chemother Pharmacol; 2006 Jun; 57(6):796-800. PubMed ID: 16142488
[TBL] [Abstract][Full Text] [Related]
64. Topotecan in squamous cell carcinoma of the cervix: A Phase II study of the Gynecologic Oncology Group.
Bookman MA; Blessing JA; Hanjani P; Herzog TJ; Andersen WA
Gynecol Oncol; 2000 Jun; 77(3):446-9. PubMed ID: 10831357
[TBL] [Abstract][Full Text] [Related]
65. A phase I and pharmacodynamic study of fludarabine, carboplatin, and topotecan in patients with relapsed, refractory, or high-risk acute leukemia.
Cooper BW; Veal GJ; Radivoyevitch T; Tilby MJ; Meyerson HJ; Lazarus HM; Koc ON; Creger RJ; Pearson G; Nowell GM; Gosky D; Ingalls ST; Hoppel CL; Gerson SL
Clin Cancer Res; 2004 Oct; 10(20):6830-9. PubMed ID: 15501959
[TBL] [Abstract][Full Text] [Related]
66. A phase II study of paclitaxel in advanced bronchioloalveolar carcinoma (EORTC trial 08956).
Scagliotti GV; Smit E; Bosquee L; O'Brien M; Ardizzoni A; Zatloukal P; Eberhardt W; Smid-Geirnaerdt M; de Bruin HG; Dussenne S; Legrand C; Giaccone G;
Lung Cancer; 2005 Oct; 50(1):91-6. PubMed ID: 16019107
[TBL] [Abstract][Full Text] [Related]
67. Carboplatin, vindesine, 5-fluorouracil-leucovorin and 13-cis retinoic acid in the treatment of advanced non-small cell lung cancer. A phase II study.
Recchia F; De Filippis S; Pompili PL; Rosselli M; Saggio G; Ciorra A; Piccinini M; Rea S
Clin Ter; 1999; 150(4):269-74. PubMed ID: 10605163
[TBL] [Abstract][Full Text] [Related]
68. A phase I/II trial of weekly topotecan and carboplatin in potentially platinum-sensitive relapsed ovarian and peritoneal carcinoma.
Rose PG; Smrekar M; Haba P; Visser C; Beeler JF
Gynecol Oncol; 2005 Dec; 99(3):714-9. PubMed ID: 16112177
[TBL] [Abstract][Full Text] [Related]
69. A phase I and translational study of sequential administration of the topoisomerase I and II inhibitors topotecan and etoposide.
Hammond LA; Eckardt JR; Ganapathi R; Burris HA; Rodriguez GA; Eckhardt SG; Rothenberg ML; Weiss GR; Kuhn JG; Hodges S; Von Hoff DD; Rowinsky EK
Clin Cancer Res; 1998 Jun; 4(6):1459-67. PubMed ID: 9626463
[TBL] [Abstract][Full Text] [Related]
70. Myelotoxicity of oral topotecan in relation to treatment duration and dosage: a phase I study.
Stathopoulos GP; Ardavanis A; Papakotoulas P; Pectasides D; Papadopoulos G; Antoniou D; Athanasiadis A; Trafalis D; Anagnostopoulos A; Koutantos J; Vaslamatzis M
Anticancer Drugs; 2010 Feb; 21(2):202-5. PubMed ID: 20010424
[TBL] [Abstract][Full Text] [Related]
71. A phase 2 trial of ifosfamide/mesna as salvage therapy in patients with ovarian cancer refractory to or relapsing after prior platinum-containing chemotherapy.
Sørensen P; Pfeiffer P; Bertelsen K
Gynecol Oncol; 1995 Jan; 56(1):75-8. PubMed ID: 7821851
[TBL] [Abstract][Full Text] [Related]
72. [Chemotherapy of small-cell lung cancer by a combination of teniposide, ifosfamide and carboplatin].
Moro D; Orfeuvre H; Nagy-Mignotte H; Mousseau M; Blanc-Jouvan F; Schaerer R; Brambilla C
Bull Cancer; 1994 Jan; 81(1):38-42. PubMed ID: 7949582
[TBL] [Abstract][Full Text] [Related]
73. Phase II study of weekly topotecan in patients with recurrent or persistent epithelial ovarian cancer.
Levy T; Inbar M; Menczer J; Grisaru D; Glezerman M; Safra T
Gynecol Oncol; 2004 Dec; 95(3):686-90. PubMed ID: 15581982
[TBL] [Abstract][Full Text] [Related]
74. [Clinical study of combination chemotherapy with cisplatin, ifosfamide, 5-FU (CIF therapy) of inoperable adenocarcinoma and large cell carcinoma of the lung].
Fujita A; Sasaki H; Mori T; Nakajima S; Sekine K; Inoue Y; Honda R; Asakawa M; Suzuki A
Gan To Kagaku Ryoho; 1991 Jan; 18(1):51-5. PubMed ID: 1846283
[TBL] [Abstract][Full Text] [Related]
75. Phase I study of combined pegylated liposomal doxorubicin with protracted daily topotecan for ovarian cancer.
Mirchandani D; Hochster H; Hamilton A; Liebes L; Yee H; Curtin JP; Lee S; Sorich J; Dellenbaugh C; Muggia FM
Clin Cancer Res; 2005 Aug; 11(16):5912-9. PubMed ID: 16115933
[TBL] [Abstract][Full Text] [Related]
76. Topotecan in the treatment of non-small cell lung cancer.
Perez-Soler R
Semin Oncol; 1997 Dec; 24(6 Suppl 20):S20-34-S20-41. PubMed ID: 9425959
[TBL] [Abstract][Full Text] [Related]
77. Doublet regimen of cisplatin plus docetaxel for second-line chemotherapy after prior therapy with cisplatin plus irinotecan for non-small cell lung cancer: a phase II study.
Seto T; Takezako Y; Nakamura H; Takeda K; Inoue F; Semba H; Eguchi K
Int J Clin Oncol; 2004 Oct; 9(5):378-82. PubMed ID: 15549588
[TBL] [Abstract][Full Text] [Related]
78. Analysis of long-term survivors after platinum containing chemotherapy in advanced non-small cell lung cancer.
Satoh H; Ishikawa H; Yamashita YT; Naito T; Takahashi H; Kamma H; Ohtsuka M; Hasegawa S
Anticancer Res; 1998; 18(2B):1295-8. PubMed ID: 9615805
[TBL] [Abstract][Full Text] [Related]
79. Phase II trial of the histone deacetylase inhibitor pivaloyloxymethyl butyrate (Pivanex, AN-9) in advanced non-small cell lung cancer.
Reid T; Valone F; Lipera W; Irwin D; Paroly W; Natale R; Sreedharan S; Keer H; Lum B; Scappaticci F; Bhatnagar A
Lung Cancer; 2004 Sep; 45(3):381-6. PubMed ID: 15301879
[TBL] [Abstract][Full Text] [Related]
80. Sequential dose-dense doxorubicin and ifosfamide for advanced soft tissue sarcomas: a Phase II trial by the Spanish Group for Research on Sarcomas (GEIS).
Maurel J; Fra J; López-Pousa A; García del Muro X; Balañá C; Casado A; Martín J; Martínez-Trufero J; de las Peñas R; Buesa JM;
Cancer; 2004 Apr; 100(7):1498-506. PubMed ID: 15042685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
